Fitness for treatment in advanced prostate cancer populations remains a significant barrier to accessing therapies for patients with a poor performance status. Among this, muscle wastage can significantly affect performance status and consequentially compromise cancer therapy. Exercise was regarded as a ...
Healthcare practitioners used that algorithm almost exclusively and virtually unchanged for the ensuing 10 years. Then, in the spring of 2010, the algorithm changed substantially for patients with advanced prostate cancer. Two new therapies were approved for use in patients with post-docetaxel, ...
NEW YORK -- Researchers have found long-term evidence that actively monitoring localized prostate cancer is a safe alternative to immediate surgery or radiation. The results, released Saturday, are encouraging for men who want to avoid treatment-related sexual and incontinence problems, said Dr. Stac...
Firmagon® (degarelix for injection) works towards achieving low testosterone levels for patients with advanced prostate cancer (APC). Learn more about Firmagon®. See the full ISI.
This study aimed to explore the opinions of healthcare professionals regarding the management of men with advanced prostate cancer with particular emphasis on treatment timing and sequencing; treatment adverse-effects and exercise a supportive therapy. Semi-structured interviews with a purposively selected...
Through the development of new specific STAT3-inhibitors with galiellalactone as a model, the researchers hope to develop targeted therapies that attack the stem cell-like cancer cells in prostate cancer and prevent the tumour from growing and spreading. ...
CHICAGO, June 4 (Xinhua) -- A combination of two existing prostate cancer therapies could extend lives of men with advanced, high-risk prostate cancer, a study showed. The addition of Zytiga to androgen-deprivation therapy can "significantly" increase overall survival in men with newly diagnosed...
transurethral resection of the prostate (TURP), is used to relieve symptoms but does not remove all of the cancer. TURP is often used in men who cannot have a radical prostectomy because of advanced age or illness or in men who have a noncancerous enlargement of the prostate. In men ...
Tunn UW: Advanced prostate cancer treatment guidelines: European perspective. BJU Int 2004, 94 Suppl 3:6.Tunn UW: Advanced prostate cancer treatment guidelines: European perspective. BJU Int 2004, 94(Suppl 3):6.Tunn UW. Advanced prostate cancer treatment guidelines: European perspective. BJU ...
the amount and activity of testosterone, the growth of advanced prostatecanceris slowed. Hormone (endocrine) therapy, known as androgen ablation or androgen suppression therapy, is the main treatment for advanced prostate cancer. It is the first line of treatment for metastatic prostate cancer. ...